2023-08-30 06:30:24
While France is deploying the Innovation France 2030 plan, cancer remains the main cause of death in the territory. Let’s see the actions put in place to fight more effectively once morest this global scourge.
In France, as in all developed countries, cancer is the main cause of death. According to the Pasteur Institute, nearly 1,000 people[1] in France who, every day, learn that they have cancer. Globally, these are more than 18 million new cases of cancer which are detected each year.
The risk factors are known: thus, external factors, such as an unbalanced diet, the consumption of tobacco and alcohol, hormonal treatments, among others, have been documented for many years. Internal factors, such as age and heredity, also play a role in the possibility of developing cancer.
Today, the cancers developed by women are mainly breast cancer, lung cancer, and colorectal cancer.
In men, lung and colorectal cancers are also predominant, as well as prostate cancer.
For several decades, successive governments have implemented national strategies to fight once morest external factors, in particular via communication campaigns to eat better, limit alcohol consumption, or fight once morest smoking, by regularly increasing the price cigarettes for example. It is now estimated that the four main risk factors – diet, overweight, tobacco, alcohol – are the cause of at least 40% of cancers diagnosed each year in France.[2].
Through the desire to modernize its health system, the Health Innovation 2030 plan wants to bring back a dose of sovereignty to the French healthcare industry, while modernizing it and improving its competitiveness.
This transition to a more efficient healthcare system obviously requires the implementation of more effective means of fighting cancer. This involves the creation of a biocluster, the Paris Saclay Cancer Cluster (PSCC)which will serve as a kind of incubator to improve the fight once morest cancer.
The PSCC, like the other bioclusters, is supported by the State, and should allow the establishment of a center of excellence that brings together companies, care, research and breakthrough innovation. Also, the stated ambition, via the creation of this biocluster, is to attract talent to our territory, and to retain skills by bringing them together in the same place of excellence. As such, five players in the health sector are working together to make the PSCC a European and world leader in the fight once morest cancer: Gustave Roussyl’Polytechnic Institute of Parisl’Inserm, Sanofi and theParis-Saclay University. This centralization of skills is an effective tool for promoting the development of a true large-scale innovation ecosystem bringing together the key players in oncology innovation within a single site located in Villejuif, with clear objectives.
First, the desire to support more than half a million people a year in the prevention, diagnosis, treatment and monitoring of cancer. In the same vein, the relocation of capacities for innovation and development of new therapies once morest cancer should make it possible to fight this disease more effectively, and to develop an industrial ecosystem around more efficient and innovative oncology.
Resulting from a public-private partnership, the PSCC houses, within a single site located in Villejuif, the key players in theoncological innovation : today, 48 research teams and more than 31 start-ups are gathered in Villejuif. The State supports the PSCC to the tune of 100 million euros over 10 yearsdepending on the achievement of the objectives set by the Health Innovation plan.
The structuring of the fight once morest cancer, through the creation of the PSCC, is a good illustration of the strategy of the France 2030 plan: to create, by relocating skills and talents to the same place, competitive clusters at the global level in the different sectors of health, such as oncology for example.
[1] et [2] Source Pastor Institute
1693714170
#Health #Innovation #measures #fight #cancer
